omnadren cycle

Taurine is a sulfur-containing amino acid produced by the body in the process of converting a cysteine. It stimulates the repair and regeneration processes at dystrophic diseases and diseases accompanied by a sharp violation of the eye tissue metabolism.

It promotes normalization of functions of cell membranes, activation energy and metabolism, preservation of the electrolyte composition of the cytoplasm due to the accumulati onomnadren cycle, improve the conditions of the nervous impulse.

When applied topically, systemic absorption is low.

Indications for use:

The drug is prescribed for adults with:

-Distrofiyah Cornea – senile, traumatic, radiation and other types of cataracts omnadren, corneal -Travmah (as a stimulator of reparative processes); -Pervichnoy open-angle glaucoma in combination with a (3-blockers (to improve the outflow of aqueous humor).

For all indications a drug used as part of combination therapy.


Individual omnadren cycle hypersensitivity to taurine, children up to 18 years.

Pregnancy and lactation: Sufficient experience with the use of the drug during pregnancy, breast-feeding is not. Perhaps the use of taufon for the treatment of pregnant and lactating mothers prescribed by a doctor, if the expected therapeutic effect is greater than the risk of possible side effects.

Dosage and administration:

When cataracts Taufon administered omnadrenu in the form of instillation to 1 to 2 drops 2-4 times a day for three months. The course is repeated at monthly intervals. For injuries and degenerative diseases of the cornea is used in the same doses in one month.

In open-angle glaucoma (in combination with butilaminogidroksipropoksifenok-simeto metiloksadiazolom and combined forms or timolol) -by 1 to 2 drops 2 times a day, 15-20 minutes prior to the appointment of one of the antihypertensive agents, for 6 weeks and then cancel 2 weeks.

Side effect:

allergic reactions.

If these instructions are compounded by the side effects, or if you notice any other side effects not mentioned in the instructions, inform the doctor.


Data on overdose are not available.

Interaction with other drugs:

In patients with glaucoma (open-) showed a significant increase in the hypotensive effect of b-blockers (timolol and butilaminogidroksi-propoksifenoksimetil metiloksadiazola) in the case of a joint application with taufon.

Strengthening effect is achieved by increasing the ratio of lightness outflow and reducing aqueous humor omnadren cycle production.

Product form:

4% eye drops. 10 ml tube-droppers with the instructions for use of the drug, and instructions on the use of tube-dropper in a pile of cardboard partitions or without partitions.